Selenocysteine incorporation directed from the 3′UTR: Characterization of eukaryotic EFsec and mechanistic implications
Marla J. Berry(University of Hawaiʻi at Mānoa), Dolph L. Hatfield(Northwestern University), Xue‐Ming Xu(National Institutes of Health), Rosa M. Tujebajeva(Brigham and Women's Hospital), John B. Mansell(Brigham and Women's Hospital), Paul R. Copeland(Rutgers, The State University of New Jersey), Elisabeth Grundner‐Culemann, Bradley A. Carlson(National Cancer Institute), Susan C. Low(Genesis Foundation), Glover W. Martin(Brigham and Women's Hospital), Donna M. Driscoll(Cleveland Clinic), John W. Harney(Brigham and Women's Hospital)
Cited by 70
Related Papers
Selenoproteins: Molecular Pathways and Physiological Roles
|Physiological Reviews|2014|1.4k
Selenium and selenocysteine: roles in cancer, health, and development
|Trends in Biochemical Sciences|2014|704
How Selenium Has Altered Our Understanding of the Genetic Code
|Molecular and Cellular Biology|2002|682
A novel RNA binding protein, SBP2, is required for the translation of mammalian selenoprotein mRNAs
|The EMBO Journal|2000|399
Eukaryotic selenoproteins and selenoproteomes
|Biochimica et Biophysica Acta (BBA) - General Subjects|2009|355